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TauEducation and cognitive occupations are commonly associated to reduce risk of Alzheimer's disease (AD) or
dementia. Animal studies have demonstrated that cognitive stimulation (CS) achieved by social/physical ac-
tivities and/or enriched environments compensates for memory decline. We have elaborated a novel para-
digm of CS that is devoid of physical/social activity and enriched environments. 4 month-old Tg2576 mice
were cognitively trained for 8 weeks and, after a break of 8 months, long-lasting effects of CS on cognitive
abilities and AD-like pathology were measured. Morris Water Maze (MWM) and Novel Object Recognition
(NOR) tests showed that deﬁcits in spatial and recognition memories were compensated by CS. These out-
comes were accompanied by increased levels of hippocampal post-synaptic markers (PSD95 and NR1) and
proteins involved in synaptic formation (Arc, β-catenin). CS softened amyloid pathology in terms of reduced
levels of Aβ1–42 and the dodecameric assembly, referred as Aβ*56. CS appeared to affect the APP processing
since differences in levels of ADAM17, BACE1 and C99/C83 ratio were found. Tau hyper-phosphorylation and
high activities of tau kinases were also reduced by CS. In contrast, CS did not induce any of these molecular
changes in wild-type mice. The present ﬁndings suggest beneﬁcial and long-lasting effects of CS early in
life on cognitive decline and AD-like pathology.
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Dementia is a syndrome deﬁned by clinical abnormalities in such
cognitive abilities as memory, attention and problem solving. The
most common form of dementia is Alzheimer's disease (AD). Aetiology
of sporadic AD (99% of cases) may be the result of the combination of
several genetic and environmental factors. Although the pathological
traits of AD are present long before patientsmanifest clinical symptoms,
an associative link between them does not have to be necessarily im-
plied. Accordingly, numerous neuroimaging and autopsy observations
have brought to light the disparity about clinical and pathological corre-
lates. This lack of association is conceptualised by the hypothesis of
“cognitive reserve”, and is likely to be regarded as life environmental
factor-inducedmechanisms that help inmaintaining the cognitive abil-
ity in the face of deleterious AD pathology [1]. Epidemiological studies
have determined education [2], cognitively complex occupations [3,4],
leisure activities [5], and to a lesser extent, physical activity [6], as theve stimulation; MWM, Morris
ype
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rights reserved.most important protective factors that can delay or prevent the onset
of clinical symptoms. Although little improvement of cognitive function
has been observed in humans after “brain training” sessions, further
empirical evidences from animal studies are required [7].
Murine models of AD and other neurodegenerative diseases have
been tested in enriched environment (EE) paradigms that are initially
aimed at stimulating cognitive activities. Exposure of EE animal
models of AD has reported both prevention of cognitive dysfunction
[8–10] or little or no effect on memory [11,12]. Some controversies
about the effects on amyloid pathology have also been reported
[13–15]. A key question lies on the interpretation of what the EE is
modelling. For example, EE may be modelling a normal daily life-
style relative to standard housing as a deprivation state instead [16].
Another point refers to the complexity of EE protocol. It usually
requires the exposition to physical activity, social interaction or
enriched environments, therefore making hard the identiﬁcation of
the relative contribution of each factor to the observed cognitive ben-
eﬁts. In this sense, isolated social or physical enrichment was
reported to occur with either insufﬁcient or poor cognitive beneﬁts
[9,17,18], suggesting that enhanced cognitive stimulation is also re-
quired. A paradigm for cognitive enrichment evading other types of
sensory-motor stimulations might be developed in order to provide
support to the hypothesis formulated by epidemiological data that in-
tellectual occupations contribute to cognitive reserve and, eventually,
compensation for AD pathology.
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protocol for cognitive stimulation (CS) that comprises a long training
on problem-solving tasks. The transgenic mice Tg2576 and their
wild-type littermates were used to study the long-term effects of cog-
nitive stimulation on AD pathology and cognitive functioning.
2. Material and methods
2.1. Animals
Sixteen female transgenic mice (Tg2576) over-expressing human
amyloid precursor protein (hAPP) carrying the Swedish familial muta-
tion (K670N/M671L) [19] under the genetic mixed hybrid background
C57BL/6/SJL and sixteen wild-type littermates (WT) with the same ge-
netic background were used. At the age of 3 months, the mice were
housed in standard laboratory cages (43 × 27 × 15 cm) in groups of
4. All mice were kept in the same room under controlled temperature
(21 ± 1 °C) and humidity (55 ± 5%) on a 12-h light–dark cycle. Cage
bottoms, water bottles and sipper tubes were cleaned twice per week,
wire lids were cleaned monthly, and food/water were provided ad
libitum. All the animals were handled under the same conditions and
by the same experimenters throughout the duration of experiments in
order to avoid potential inﬂuence on cognition.
As described later in the text, following the assessment of memory
function through a short version of Morris Water Maze, the mice
were assigned to “cognitive stimulation” (CS) or “naïve” groups in
order to create uniform groups in terms of basal cognitive function.
Experimental procedures were conducted in accordance with the
European and Spanish regulations (2003/65/EC; 1201/2005) and ap-
proved by the Ethical Committee of University of Navarra (068-11).
2.2. Cognitive stimulation paradigm
Cognitive stimulation paradigm was aimed at keeping the mice
cognitively active for a period of 8 weeks. For this purpose, the mice
were allowed to ﬁnd and learn the pathway to reach a goal through
a Lashley-type maze. The goal consisted of a food stimulus, in partic-
ular a piece of wheaten “digestive” biscuit. This paradigm intends to
generate a response learning, where mice choose the correct se-
quence of right–left responses depending on which choice led them
to the food stimulus in previous trials. The food stimulus reinforces
the correct choices. No extra-maze cues were allowed in order to
avoid place learning. Cognitive stimulation was induced by exposing
mice to solve 8 different problems, one per week. 8 different
Lashley-type mazes were manufactured in our lab, having every
maze (made of black wooden walls: 27 × 54 × 18 cm) a unique de-
sign so that there is only one pathway, different to each other maze,
to reach the goal. A schematic illustration of each maze can be seen
in Fig. 1A. The animals were trained for 4 days (Monday, Tuesday,
Wednesday and Friday) and 2 trials per day in each of the 8 mazes
for 8 weeks. Number of entry errors and latency to reach the goal
was measured as the main outcomes. Three criteria were applied in
order to achieve a stimulus-induce seeking of the goal and attain
standard levels of learning among mice: 1) Trial was considered ﬁn-
ished only after a mouse that reached the goal stayed the sufﬁcient
time to savour the food reward. 2) Mice that did not fulﬁl the ﬁrst cri-
terion after expiring the trial time (maximum of 10 min) were gently
guided all along the successful path from the start to the goal and
forced them to stay there until they savoured the reward. 3) The
mice were kept in fasting conditions on Tuesdays and Fridays in
order to induce conditioned seeking towards food stimulus. Mice
were normally fed on Wednesdays. Mice were not trained on Thurs-
days in order to avoid another fasting day.
Animals subjected to cognitive stimulation are referred as “CS”mice.
To discard whether the effects of this training protocol could be attrib-
utable to the inherent physical and exploratory activity needed toperform the task, one subset of mice from each genotypewas subjected
to an open-ﬁeld environment in order to provide these control animals
with a similar sensory stimulation, which did not require any stimulus-
induced response learning (study design shown in Fig. 1B). This animal
group, which was referred as “naïve”, was also allowed to taste the
same food reward at the end of the trial.
2.3. Behavioural tests
2.3.1. Novel Object Recognition Test (NORT)
The test was performed as previously described [20]. In short, the
animals were ﬁrst familiarized with the arena for 30 min and one day
after, the mice were allowed to explore two identical objects for
5 min. Retention was assessed 1 and 24 h later, when one object
was replaced by a novel one each time. Retention score is expressed
as discrimination index (percentage of time exploring the novel ob-
ject to the total time of object exploration).
2.3.2. Morris Water Maze (MWM)
The maze consisted of a white circular tank (140 cm diameter ×
55 cm high) ﬁlled with water (20–22 °C). The test was performed
as previously described [21] with some modiﬁcations. In the hid-
den version of the acquisition phase, a 10-cm diameter white plat-
form was positioned 1 cm below the water surface and the tank
was surrounded by white curtains showing black geometric cues.
In the visible platform version, a black platform was placed 1 cm
above the water surface. Time spent to reach the platform (latency)
was recorded. The mice were trained in the MWM at two different
time points in life; ﬁrst, a short version of MWM was carried out
before the start of the experimental design in order to check
whether both WT and Tg2576 mice had similar cognitive abilities;
and second, right after the end of training procedures in order to
check its effects on memory.
Prior to the training in the CS paradigm, cognitive behaviour of
4 month-old mice was analysed by a short version of MWM. 3 days
prior to the hidden platform phase, a visible platform version was car-
ried out for 3 consecutive days and 4 trials per day with an inter-trial
interval of 2 h. Animals that showed to be ﬂoating, thigmotactic, wan-
dering and other behaviours that could affect learning were discarded
from the study, and the rest were next trained in the hidden platform
version for 3 consecutive days and 4 trials per day with an inter-trial
interval of 2 h. The retention phase (no platform) was carried out on
the 4th day. Mice were allowed to swim for 60 s and time in the tar-
get quadrant was measured. Besides checking the cognitive status of
WT and Tg2576 mice before the beginning of the training paradigm,
the short version of MWM allowed an equally distribution of animals
between CS and naïve groups in terms of cognitive abilities.
Just after the 8-week training paradigm, 15 month-old mice were
trained for 6 consecutive days and 4 trials per day with an inter-trial
interval of 2 h in the hidden platform version. To ensure that memory
differences were not due to lack of task learning, mice that did not
reach the platform were led to the platform and allowed to stay for
15 s. The visible platform version was avoided since it was performed
at the beginning of the study. The retention phase (no platform) was
carried out at the 4th and 7th days. The mice were allowed to swim
for 60 s and time in the target quadrant was measured.
2.4. Biochemical measurements
2.4.1. Protein extraction
15 month-old fastingmicewere killed by decapitation. For immune-
blotting of most of the proteins shown in the present work, proteins
were extracted from hippocampi after homogenization in HEPES buffer
saline (0.2 MNaCl, 2 mMNa4P2O7, 0.1 MHEPES, 10% glycerol, 200 mM,
5 mM EDTA, 1 mM EGTA, 2 mMDTT) containing protease and phospha-
tase inhibitors (NaF, 0.5 mM PMSF, 1 mM Na3VO4, 1 mM benzamidine,
Fig. 1. Study design and validation of the cognitive stimulation paradigm. (A) A schematic picture of eachmazewheremicewere trained for cognitive stimulation is shown.Note that each
maze has a unique design, that there is only one pathway to reach the goal and that the pathway is different in eachmaze. Themicewere allowed to learn the pathway to reach the goal of
every maze, which consisted of a food reward, for 1 week. Numbers from 1 to 4 refer to the days of the week when mice were allowed to explore the maze (1, Monday; 2, Tuesday, 3,
Wednesday; 4, Friday). The paradigm for cognitive stimulation included a total of 8 mazes and 8 weeks. (B) Sixteen wild-type and sixteen Tg2576 mice at the age of 4 months were
subjected to either a CS paradigm for 8 weeks or an open-ﬁeld exploration for the same period of time. Prior to CS paradigm, the animals were subjected to a short version of MWM
in order to check their basal cognitive abilities. After CS paradigm, the animals were aged for 8 months and then behavioural tests (NORT and MWM) were performed. At the age of
15 months, the animals were sacriﬁced and biochemical assessments were carried out. (C, D) To validate the induction of cognitive activity by the cognitive stimulation paradigm, escape
latency (C) and number of entry errors (D) to reach the goal and stay the sufﬁcient time to savour the food reward were measured. Mice from both genotypes showed improved escape
latencies and decreased number of entry errors in every task (week). ⁎P b 0.05, ⁎⁎P b 0.01 vs day 1 (C) or vs day 2 (D). Data are expressed as mean ± S.E.M. WT-naïve, n = 8; WT-CS,
n = 8; Tg2576-naïve, n = 8; Tg2576-CS, n = 8.
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were centrifuged at 14,000 g for 20 min at 4 °C, and supernatant stored
at−80 °C.
For immune-blotting of APP-derived fragments, proteins were
extracted from hippocampi after homogenization in a buffer containing
Tris–HCl (10 mM, pH 7.4), SDS 2% and protease and phosphatase inhib-
itors. Homogenates were sonicated and centrifuged at 100,000 g for
1 h. Supernatant was stored at−80 °C. Protein concentration was de-
termined by Bradford (Bio-Rad, Hercules, CA, USA).
For ELISA determination of Aβ1–42 and Aβ1–40 peptides from soluble
and insoluble fractions, protein were extracted as follows: hippocampi
were homogenized in 4 volumes of Tris–HCl buffer saline (25 mM
Tris–HCl, 2 mM 1,10-phenanthroline, 5 mM EDTA, 140 mM NaCl,
3 mM KCl, pH 7,4) containing a protease inhibitor cocktail from
Roche. Homogenates were centrifuged at 100,000 g for 1 h at 4 °C.
Supernatant contained the “soluble fraction” and pellet contained the
“insoluble fraction”. To prepare the insoluble fraction, pellet was
dissolved in 4 volumes of ice-cold guanidine buffer (5 M guanidine–
HCl, 50 mM Tris–HCl, pH 8.0) diluted 1:20. After over-night mixing at
room temperature in DPBS buffer containing 5% BSA and 0.03%
Tween-20, sample was centrifuged at 20,000 g for 20 min at 4 °C.
2.4.2. Immuno-blotting
Samples were mixed with equal volume of loading buffer (0.16 M
Tris–HCl pH 6.8, 4% SDS, 20% glycerol, 0.01% bromophenol blue, 0.1 M
DTT) and ran in SDS-PAGE. Proteins were transferred to BioTrace™Nitrocellulose membranes (Pall Corporation, Port Washington, NY,
USA). Gel conditions and primary antibodies are summarized
in Table 1. Secondary antibodies conjugated to IRDye 800CW or
IRDye 680CW (LI-COR Biosciences, Lincoln, NE, USA) were diluted
to 1/15,000 in TBS with 5% BSA. Bands were visualized using Odyssey
Infrared Imaging System (LI-COR Biosciences, Lincoln, NE, USA).
β-Actin was used as loading control. Results were expressed as O.D.
values relative to WT-naïve mice. For APP-derived fragments, sam-
ples were mixed with XT sample buffer plus XT reducing agent
(Bio-Rad, Hercules, CA, USA) and boiled for 5 min. Proteins were
transferred to PVDF membranes (Amersham Biosciences, Bucking-
hamshire, UK). HRP-conjugated secondary antibodies were diluted
to 1:5000 (Dako, Glostrup, Denmark). Bands were detected by en-
hanced chemiluminescence system (ECL, Amersham Biosciences,
Buckinghamshire, UK), and autoradiographic exposure to Hyperﬁlm
ECL (Amersham Biosciences). Signal was quantiﬁed by using Quantity
One v.4.6.3 software (Bio-Rad, Hercules, CA, USA).
Note that some proteins bands were obtained as a result of strip-
ping (stripping buffer, Pierce, IL, USA) and re-probing the membrane.
However, membranes were never reused for more than 4 times
(Table 1).
2.4.3. Determination of ß-amyloid levels
As aforementioned, ß-amyloid peptides were extracted from both
the soluble and insoluble fraction. Human Aβ1–42 and Aβ1–40 levels
from Tg2576 samples were measured in duplicate by a sandwich
Table 1
Antibodies and conditions used in immuno-blotting experiments.
Protein %
Polyacrylamide
Primary antibody
(dilution)
T Lysis buffer
Arc 10% ARC (1:1000)a HBS
β-Catenin 10% β-catenin (1:1000)b 1 HBS
PSD95 10% PSD95 (1:1000)b 2 HBS
Synaptophysin 10% Synaptophysin
(1:500)c
3 HBS
APP Gradient
(4–12%)h
APP 676–695
(1:2000)d
0 Tris–HCl
C99/C83 Gradient
(4–12%)h
APP 676–695
(1:2000)d
0 Tris–HCl
Aβ*56
(dodecamer)
Gradient
(4–12%)h
β-amyloid 1–16
(6E10) (1:1000)e
1 Tris–HCl
ADAM17 Gradient
(4–12%)h
ADAM17 (1:1000)b 0 HBS
BACE1 Gradient
(4–12%)h
BACE1 (1:1000)c 1 HBS
Phospho-tau 10% Phospho-tau
S202/T205 (AT8)
(1:500)f
0 HBS
Total tau 10% tau (1:1000)f 1 HBS
NR1 7.5% NR1 (1:1000)g 0 HBS
NR2A 7.5% NR2A (1:1000)g 0 HBS
NR2B 7.5% NR2B (1:1000)g 1 HBS
VGLUT1 10% VGLUT1 (1:1000)g 4 HBS
MAP2A 10% MAP2 (1:1000)g 2 HBS
Cdk5 7.5% cdk5 (1:1000)a 0 HBS
p35/p25 7.5% p35 (1:1000)a 1 HBS
Phospho-GSK-3β
Ser9
7.5% Phospho-GSK-3β S9
(1:1000)b
0 HBS
Phospho-GSK-3β
Tyr207
7.5% Phospho-GSK-3β Y207
(1:1000)b
1 HBS
Total GSK-3β 7.5% GSK-3β (1:1000)b 2 HBS
“T” refers to the number of times that membranes were stripped before probing with
the corresponding antibody.
HBS, HEPES buffer saline containing protease and phosphatase inhibitors, and NP-40.
Tris–HCl, Tris–HCl buffer containing protease and phosphatase inhibitors, and SDS 2%.
a Santa Cruz Biotechnology, Santa Cruz, CA, USA.
b Cell Signalling Technology, Danvers, MA, USA.
c Abcam, Cambridge, UK.
d Sigma-Aldrich, St. Louis, MO, USA.
e Covance, Princeton, NJ, USA.
f Pierce, Rockford, IL, USA.
g Millipore, Billerica, MA, USA.
h Bio-Rad, Hercules, CA, USA.
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manufacturer's instructions. The detection range was 6–1000 pg/ml.
Murine Aβ1–42 from WT samples were analysed in duplicate by a
high-sensitive sandwich ELISA kit (Dako, Glostrup, Denmark). The
detection range was 0.5–100 pg/ml.
2.4.4. Amyloid plaque staining
Left hemispheres from 4 mice per group were ﬁxed by immersion
in 4% paraformaldehyde in 0.1 M PBS (pH 7.4) for 24 h followed by
10% sucrose solution. Brains were cut into series of 20 μm slides.
Free-ﬂoating sections were incubated in 70% formic acid for 10 min,
and then blocked with 2% of normal goat serum in PBS with 0.3%
TritonX-100 for 30 minprior to incubationwith 6E10primary antibody
over-night at 4 °C. Then, sections were incubated with secondary anti-
body (1:500; Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 2 h
in blocking solution, followed by incubation in ABC-Elite HRP (Vector
Laboratories, Burlingame, UK). Reactionswere visualized by developing
the sections in DAB (Vector Laboratories, Burlingame, UK). Sections
were rinsed in PBS, dehydrated and mounted in DPX (BDH, Poole,
UK). For control staining the primary antibody was omitted. 8 sec-
tions per hippocampus were processed and captured into images
with Nikon Eclipse E800 microscope and Nikon FDX35 camera. Area
covered by amyloid plaques was analysed by ImageJ v. 1.43u software
(NIH Image).2.5. Statistical analysis
All results are expressed as mean ± standard error of the mean
(SEM). The outcomes measured in the cognitive stimulation para-
digm were analysed by one-way ANOVA (genotype (WT/Tg2576))
with and additional factor (days) as repeated measurement for each
week. As no signiﬁcant interaction between genotype and days was
found, main effect of “days” was assessed by one-way ANOVA
followed by Tukey's test. Biochemical data were evaluated by two-
way ANOVA (genotype (WT/Tg2576), training (naïve/CS)). When in-
teraction between factors was signiﬁcant, single effects were
analysed by one-way ANOVA followed by post hoc Tukey's test. The
value from F of interaction together with the probability associated
to the single comparison was indicated. When no signiﬁcant interac-
tion between factors was found, main effects were analysed. Statisti-
cal analysis of MWM acquisition was performed by two-way ANOVA
with an additional factor (days) as repeated measurement. When in-
teraction between factors was found, intra-group differences were
checked by one-way ANOVA followed by Tukey's test. In those cases
where only two groups were compared, data were evaluated by
Student's t test. Number of animals per group ranged from 6 to 8.
The level of signiﬁcance was set at P b 0.05. All analyses were
performed using SPSS 15.0 packages of Windows (IL, USA).
3. Results
3.1. Effects of cognitive stimulation on memory and synaptic markers
Prior to training, cognitive function ofmicewas tested in a short ver-
sion of the MWM (3 days of acquisition in the hidden platform version
plus a probe trial in the next day). Normal cognitive abilities were con-
ﬁrmed as both WT and Tg2576 showed better escape latencies on the
3rd day of the hidden platform (main effect of “Day”; F(2,45) = 5.66,
P b 0.05 vs 1st day, WT group; F(2,45) = 3.92, P b 0.05 vs 1st day,
Tg2576 group) as well as on the visible platform version (main effect
of “Day”; F(2,45) = 14.04, P b 0.01 vs 1st day, WT group; F(2,45) =
18.72, P b 0.01 vs 1st day, Tg2576 group) (Fig. S1A–C).
The mice were considered to have achieved a successful perfor-
mance when latency to reach the goal was signiﬁcantly reduced
from the 1st day to the last (4th). No improvement would have indi-
cated a lack of learning, and therefore, a fail in the purpose of induc-
ing cognitive stimulation. Notably, the mice showed improved escape
latencies and decreased number or entry errors to ﬁnd the goal over
days (main effect of “day”; Week 1 as a representative example:
F(1,28) = 8.89, P b 0.01 for escape latency; F(1,28) = 12.33, P b 0.01
for number of entry errors; see Fig. 1C and D). A video recorded the
4th day of week 7 shows a Tg2576 mouse that was able to reach
the goal with no entry errors (Supplementary material). As it can be
observed, transgenic animals showed a better performance, which
was particularly evident at weeks 4 and 5. A possible beneﬁcial effect
of β-amyloid on learning at a young age, when levels are not high
enough to cause neurodegeneration [22], cannot be ruled out.
After the training sessions the mice were kept in standard-housing
conditions for 8 months until the age of 15 months-old. Then, effects
of CS on memory were assessed by two different behavioural tests:
MWM and NORT. These tasks are mainly dependent on spatial and rec-
ognition memory, respectively, which are two types of memory largely
affected in AD and Tg2576 mice as well [19,23]. This long lag between
the end of CS paradigm and the beginning of cognitive characterization
is due to the onset of cognitive decline in Tg2576 mice. Despite some
discrepancies about the onset of spatial memory impairment in
Tg2576 mice [19,24,25], the age of 14–15 months seems to be proper
for detecting decline in both types of memories [21,26]. As expected,
Tg2576-naïve mice displayed impaired retention memories in the
probe trials carried out at day 4 (F(1,26) = 8.02, P b 0.05 vs WT-naïve;
Fig. 2A) and 7 (F(1,26) = 9.74, P b 0.01 vs WT-naïve; Fig. 2A).
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(data not shown), did not achieve signiﬁcant longer escape latencies
during the acquisition phase (Fig. 2B). It is important to note that
Tg2576-naïve mice did not show lower escape latencies over days,
which means that they were not able to learn the platform location
(F(5,35) = 1.51, P = 0.21),while Tg2576-CSmice did shorten escape la-
tency to platform over days (F(5,30) = 2.63, P b 0.05; Fig. 2B). No signif-
icant differences on escape latencies between groups were found in the
visible platform version as well (data not shown). Regarding memory
retention, transgenic animals subjected to CS presented better perfor-
mance in both probe trials, reaching similar retention scores than WT
animals (Fig. 2A). In contrast, WT animals subjected to CS did not per-
form better retention than WT-naïve (Fig. 2A). In the same manner,
Tg2576-naïve mice showed impaired object recognition memory as
they did not preferentially discriminate in favour of the novel object
(F(1,26) = 8.94, P b 0.01 vs WT-naïve, 1 h; F(1,26) = 6.22, P b 0.01 vs
WT-naïve, 24 h) but, interestingly, Tg2576-CS achieved similar discrim-
ination indexes than WT-naïve mice at both retention times (Fig. 2C).
It is well accepted that hippocampal synaptic plasticity is essential
for mediating the formation of new memories [27]. The observed im-
provement of memory abilities in cognitive-stimulated Tg2576 mice
might be thus attributable to different expression levels of long-
term activity-associated synaptic proteins. To test this hypothesis,
we then assessed the state of several synaptic markers. Pre-synaptic
markers were found either unaltered, as the case of synaptophysin,
or decreased, as the case of VGLUT-1 (F(1,21) = 7.74, P b 0.05), butFig. 2. Cognitive stimulation delays the memory deﬁcits observed in 16-month-old Tg2576
target quadrant over a total duration of 60 s. At both the 4th and 7th day after the beginnin
stimulation. (B) In the hidden platform version of acquisition, no signiﬁcant differences on es
manage to lower escape latency to ﬁnd the platform over days, Tg2576-CS as well as WT-n
recognition memory, as shown by decreased discrimination index to a novel object, both 1
recognition memory, which only reached the level of signiﬁcance at 24 h post-training. ⁎P b
as mean ± S.E.M. WT-naïve, n = 7; WT-CS, n = 8; Tg2576-naïve, n = 8; Tg2576-CS, n =unaffected by CS (Fig. 3A). Interestingly, some proteins recruited
into the post-synaptic density as PSD95 and its partner the NR1
subunit of NMDA receptors (Fig. 3B), as well as such proteins in-
volved in synaptic consolidation and formation as Arc and β-catenin
(Fig. 3C), were found decreased in Tg2576 mice (PSD95, F(1,21) =
10.85, P b 0.05; NR1, F(1,23) = 30.96, P b 0.01; Arc, F(1,23) = 5.425,
P b 0.01; β-catenin, F(1,23) = 6.26, P b 0.05), but preserved by CS.
3.2. Decreased soluble Aβ species but constant plaque burden in Tg2576
mice subjected to cognitive stimulation
Accumulating evidence supports soluble Aβ oligomers, rather
than Aβ ﬁbrils, as fundamental triggers for the pathological and cog-
nitive symptoms observed in AD [28]. We found that SDS-soluble
Aβ1–42 and Aβ1–40 levels in cognitive-stimulated Tg2576 mice were
reduced by 40% and 20%, respectively, when compared to the naïve
group (t(1,12) = 5.86, P b 0.01 for Aβ1–42; t(1,12) = 2.46, P b 0.05 for
Aβ1–40; Fig. 4A). Tg2576-CS mice presented unchanged levels of in-
soluble GuHCl-extracted Aβ1–40 and a slight but signiﬁcant decrease
in Aβ1–42 (t(1,12) = 5.72, P b 0.01) (Fig. 4A). In contrast, CS did not
appear to affect the levels of murine Aβ1–42 in either the soluble or in-
soluble fraction of WT brains (Fig. 4A).
The total burden of 6E10-immunoreactive amyloid plaques
remained similar in both groups as well (Fig. 4B). These results indi-
cate that CS is likely to induce major changes in the levels of soluble
Aβ; however, it fails to provide real information about which Aβmice, as studied by MWM (A–B) and NOR (C) tests. (A) Percentage of time spent in the
g of training Tg2576 mice showed impaired retention, which was reverted by cognitive
cape latencies were found between groups. However, while Tg2576-naïve mice did not
aïve and WT-CS mice did. ⁎P b 0.05, day 6 vs day 1. (C) Tg2576 mice showed impaired
and 24 h after training with 2 similar objects. Tg2576-CS mice presented a recovered
0.05, ⁎⁎P b 0.01 vsWT-naïve; ^P b 0.05, ^^P b 0.01 vs Tg2576-naïve. Data are expressed
7.
Fig. 3. Cognitive stimulation protects from the synaptic pathology observed in 16 month-old Tg2576 mice. Although pre-synaptic markers as synaptophysin or the vesicular trans-
porter VGLUT1 seem to be little or no affected in hippocampus from Tg2576 (A), post-synaptic markers PSD95 and the subunit of NMDA receptors NR1, but not NR2A or NR2B, were
found decreased. Levels of PSD95 and NR1 were found signiﬁcantly increased by CS in Tg2576 mice (B). Hippocampal levels of Arc and β-catenin, which are proteins with an im-
portant role in synaptic consolidation and formation, were also found decreased in Tg2576 mice, but recovered after CS (C). Western-blot quantiﬁcations are normalized to β-actin
levels ⁎P b 0.05, ⁎⁎P b 0.01 vs WT-naïve; ^P b 0.05, ^^P b 0.01 vs Tg2576-naïve. Data are expressed as mean ± S.E.M. WT-naïve, n = 6; WT-CS, n = 6; Tg2576-naïve, n = 6;
Tg2576-CS, n = 6–8. OD refers to optical density.
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back, electrophoresis of extracellularly-enriched SDS homogenates
was run. Notably, a band around 56-kDa was found in Tg2576 sam-
ples but was absent in WT samples when immuno-blotting the
membranes with 6E10 antibody (4C). This band, which could
presumably correspond to the amyloid dodecamer (also referred as
Aβ*56) was found dramatically reduced by 45% in cognitive-
stimulated Tg2576 mice (t(1,10) = 6.19, P b 0.01; Fig. 4C). To discard
misinterpretations caused by artefacts, samples were pre-treated
with 10% hexaﬂuoroisopropanol (HFIP), an organic solvent that
breaks up Aβ oligomers, and immunoblotted again with 6E10 anti-
body, resulting in the dissolution of the 56-kDa band (Fig. 4C).
Remarkably, levels of soluble Aβ1–42 as well as Aβ*56 showed a
strong and inverse correlation to both NORT (Pearson's r = −0.90,
P b 0.01; Pearson's r = −0.70, P b 0.01, respectively) and MWM re-
tention scores (Pearson's r = −0.78, P b 0.01; Pearson's r = −0.58,
P b 0.01, respectively), suggesting an important link between de-
creased levels of soluble Aβ species and the CS-induced reversion of
cognitive deﬁcits (Fig. 4D).
The reason for such a reduction in the levels of soluble Aβmaybe due
to a modulation of APP processing. APP-derived fragments and APP
secretases were analysed by immuno-blotting. As expected, Tg2576
mice expressed higher levels of the full-length APP when compared toWT animals (F(1,23) = 2512.47, P b 0.01). However, whereas full-
length APP remained unchanged between Tg2576-naïve and Tg2576-
CS (Fig. 5A), levels of β-secretase-derived C-terminal C99 fragment
were reduced (F(1,23) = 11.46 P b 0.01) and the α-secretase-derived
C83 fragment increased (F(1,23) = 5.76, P b 0.01) in Tg2576-CS mice
(Fig. 5A). Despite steady-state levels of an enzyme do not always reﬂect
changes in activity; it was found that CS returned the augmented
β-secretase BACE1 levels observed in Tg2576-naïve mice to those of
WT-naïve animals (F(1,23) = 8.62, P b 0.01; Fig. 5B), and increased
α-secretase ADAM17 (F(1,23) = 6.72, P b 0.05; Fig. 5B). These results
might suggest a shift towards diminished amyloidogenic and augment-
ed non-amyloidogenic processing of APP.
3.3. Cognitive stimulation compensates for tau pathology in Tg2576 mice
As hyper-phosphorylation of tau is a common feature of AD and
other neurodegenerative disorders, it was next examined whether CS
might be beneﬁcial on this pathological event. According to reported
data, tau pathology in Tg2576mice in terms of altered phosphorylation
state of tau and its related kinases was observed [29]. Immuno-blotting
with AT-8 antibody revealed that phosphorylation at Ser202/Thr205
residues was markedly increased in Tg2576-naïve when compared to
WT animals (F(1,25) = 5.30, P b 0.05; Fig. 6A and E). Notably,
Fig. 4. Tg2576 mice exposed to cognitive stimulation shows reduced levels of soluble Aβ species at the age of 16 months. (A) Soluble Aβ1–40 and, particularly, Aβ1–42 assessed by
ELISA were found signiﬁcantly decreased in hippocampus of Tg2576-CS mice (left panel). However, only levels of the insoluble species Aβ1–42 presented a little and signiﬁcative
change (right panel). Levels of both soluble and insoluble murine Aβ1–42 were found unaltered in WT-CS when compared to WT-naïve mice. WT-naïve, n = 7; WT-CS, n = 7;
Tg2576-naïve, n = 8; Tg2576-CS, n = 6. (B) Immunostaining with 6E10 antibody did not show any particular change in the amyloid plaque burden between naïve and
cognitive-stimulated Tg2576 animals. Scale bar, 100 μm. Tg2576-naïve, n = 3; Tg2576-CS, n = 3. (C) Immunoblotting with 6E10 antibody revealed a band around 56 KDa,
which was present in Tg2576 mice but absent in WT mice (left panel). The fact that this band is not present in WT mice and is dissolved by pre-treating samples with HFIP,
makes this band likely attributable to the amyloid dodecamer Aβ*56. Aβ*56 was strikingly decreased by CS (middle and right panel). Tg2576-naïve, n = 5; Tg2576-CS, n = 6.
(D) Soluble levels of Aβ1–42 and Aβ*56 strongly correlated with memory retention scores at both NOR (Discrimination index; left panel) and MWM tests (Time in target zone;
right panel). Pearson's correlation coefﬁcient “r” is shown. Western-blot quantiﬁcations are normalized to β-actin levels. ⁎P b 0.05, ⁎⁎P b 0.01 vs Tg2576-naïve. Data are expressed
as mean ± S.E.M. OD refers to optical density.
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tau thanWT mice (Fig. 6A and D). No differences in total tau levels be-
tween experimental groupswere found (Fig. 6A). The activity of several
kinases involved in abnormal tau phosphorylationwas next assessed by
calculating the ratio between the phosphorylated form and the total
level of each kinase. Active GSK-3β (phospho-Tyr216) was found in-
creased (F(1,23) = 8.48, P b 0.05; Fig. 6B and F) and inactive form
(phospho-Ser9) decreased in Tg2576-naïve mice (F(1,23) = 4.87,
P b 0.05; Fig. 6B and E). CS returned GSK-3β activity to WT levels(Fig. 6B and E). In addition, despite no differences in Cdk5 levels were
detected (Fig. 6B and E), a two-fold increase of the ratio p25/p35 was
found in Tg2576-naïve mice (F(1,16) = 10.17, P b 0.01; Fig. 6B and E),
suggesting a higher constitutive activation of Cdk5 in these animals
[30]. Yet again, Tg2576-CS mice showed similar levels than WT
(Fig. 6B and E).
Tau's main function is to modulate the stability of axonal microtu-
bules. Other microtubule-associated proteins (MAPs), such as MAP2A,
are able to stabilize microtubules in dendrites as well, and its lost has
Fig. 5. Cognitive stimulation induced changes in APP processing in 16 month-old Tg2576 mice. (A) Quantiﬁcation of APP fragments revealed that Tg2576-CS mice presented lower
levels of C99 and higher C83 in hippocampus when compared to naïve transgenic mice. In contrast, full-length APP remained unchanged. (B) Tg2576-naïve mice presented higher
steady-state levels of the hippocampal β-secretase BACE1 but cognitive stimulation induced a decrease. As well, cognitive stimulation resulted in a subtle but signiﬁcant increase of
the α-secretase ADAM17 in both wild-type and transgenic animals. Quantiﬁcations are normalized to β-actin levels. ⁎⁎P b 0.01 vs WT-naïve; ^P b 0.05, ^^P b 0.01 vs Tg2576-naïve;
&P b 0.01 vs naïve (single effect). Data are expressed as mean ± S.E.M. WT-naïve, n = 6; WT-CS, n = 7; Tg2576-naïve, n = 8; Tg2576-CS, n = 6. OD refers to optical density.
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that MAP2A levels were indeed decreased in Tg2576-naïve when com-
pared toWTmice (F(1,19) = 4.51, P b 0.01) but recovered in Tg2576-CS
group (Fig. 6D and H).
Together these data suggest that CS is able to delay the tauopathy
inherent to Tg2576 mouse at the age of 15 months. It is worthy of no-
tice that decreased tau hyper-phosphorylation is strongly correlated
with reduced Aβ*56 and Aβ1–42 (Pearson's r = 0.683; P b 0.05;
Pearson's r = 0.763, P b 0.01, respectively; data not shown), howev-
er, whether cognitive stimulation prevents tau pathology directly or
secondary to modulation of amyloid pathology cannot be addressed
in the present work.
4. Discussion
In the present study, a novel training paradigm for CS, devoid of
social, physical or enriched environments, has been elaborated and
valuated. AD transgenic mice exposed to this training throughout
early-life manifested normal cognitive function, reduced synaptic
deﬁcit and decreased amyloid/tau pathology at an older age.One of the main ﬁndings is the simple and striking fact that a tran-
sient CS delays the onset of spatial and object recognition memory
decline in Tg2576 mice after a lag of 8 months. The reason by which
this CS induces strong long-lasting effects on cognitive function
might lie in the time frame where CS was applied, since early-life
stimulatory events appear to build cognitive reserve more effectively
and, therefore, make the brain less susceptible to pathological
changes. An in vivo study has added evidence on this assumption by
showing that exposure to a transient stimulation with an enriched
environment in early-life reduced the AD-related cognitive deﬁcits
more efﬁciently than exposure later in life [31]. In contrast to the ben-
eﬁcial effects of CS observed in Tg2576 mice, trained WT mice did not
show improved cognitive abilities in any of the tests performed.
These observations may indicate that CS fails to provide any supple-
ment against the physiological cognitive decline associated to ageing
[32], but may instead compensate for the memory loss associated to
AD pathogenic processes. A previous study carried out in eleven thou-
sand cognitively healthy humans subjected to “brain training” that
failed to report beneﬁts in untrained tasks might support this
assumption [7].
Fig. 6. Cognitive stimulation compensates for the tau pathology inherent to 16 month-old Tg2576 mice. (A, D) Immuno-blot with monoclonal antibody AT8 revealed that tau phos-
phorylation at residues S202 and T205 were increased in Tg2576-naïve but unchanged in Tg2576-CS mice. (B, E) Immuno-blots and quantiﬁcation of tau kinases that showed al-
tered state of activity. Levels of inactive p-S9-GSK3βwere found decreased and active p-Y207-GSK3β increased in Tg2576-naïve animals, while unchanged in Tg2576-CS mice. The
ratio p25/p35, and indicator of cdk5 activity, was also increased in Tg2576-naïve mice but unaltered in Tg2576-CS. (C, F) Levels of the microtubule-associated protein MAP2A were
found decreased in Tg2576-naïve animals but recovered in cognitive-stimulated transgenic mice. Quantiﬁcations of phospho-proteins are normalized to both total protein and
β-actin levels. ⁎P b 0.05, ⁎⁎P b 0.01 vs WT-naïve; ^P b 0.05, ^^P b 0.01 vs Tg2576-naïve. Data are expressed as mean ± S.E.M. WT-naïve, n = 6; WT-CS, n = 6; Tg2576-naïve,
n = 6–8; Tg2576-CS, n = 6. OD refers to optical density.
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player in the memory dysfunction developed by this transgenic mouse.
Although effects of amyloid load on memory may be nonlinear and ex-
hibit saturation [25], data from correlational and experimental studies
might suggest a causal role in memory disruption [33,34]. We have
found that cognitive training led to lowered soluble amyloid load
while leaving amyloid plaque burden intact. Among the different amy-
loid assemblies that are present in the soluble fraction, the dodecamer
referred as Aβ*56 was found notably reduced in CS transgenic animals.
Previous studies that identiﬁed this oligomeric form as being most
closely related to memory loss in younger Tg2576 mice [35,36] imply
a potential rationale by which CS might be compensating for the mem-
ory decline. Likewise, repeated training in a MWM over a period of
10 months reported similar beneﬁts on the levels of Aβ*56 and
MWM-relatedmemory in the 3xTg-AD transgenicmice [37]. In contrast
to this study, the present work evaluated memory abilities in untrained
tasks. Additionally, it was found a strong correlation between levels of
Aβ*56 and retention scores in MWM and NOR tests, which, although
far from providing a causal association, conﬁrms the close connection
of decreased Aβ*56 to CS-induced delay of cognitive decline. It is
hypothesized that oligomeric Aβ*56 may rise prior to the formation of
amyloid plaques, and therefore act as seeds for plaques [35,38]. Specu-
latively, CSmight be reducingAβ*56 levels by 1) decreasing the produc-
tion of monomers; 2) inducing its clearance; or 3) promoting itsaggregation into plaques. The fact that training did not alter plaque bur-
den and that Aβ*56 showed correlation to soluble but not to insoluble
levels seems to discard the latter point. In contrast, the fact that CS
showed reduced levels of C99 and BACE1, aswell as increased the levels
of C83 and ADAM17 indicates that the production ofmonomermight be
decreased, thus leaving to reduced formation of the dodecamer. Howev-
er, the idea that CSmay lower Aβ*56 loadby favouring its clearance can-
not be ruled out. It is important to note that CS likely induced a shift
towards a more non-amyloidogenic processing of APP but remained
the amyloid plaque burden intact. Although soluble amyloid species
were found indeed decreased, the production of those amyloid species
that are more prone to aggregate might have not been affected by CS.
Also noteworthy in the present study is that CS compensated for the
abnormal tau phosphorylation and high activities of GSK-3β and cdk5
found in Tg2576 mice. Although transgenic mice do not suffer from
real tau pathology in terms of neuroﬁbrillar tangles, these animals man-
ifest age-related hyperphosphorylated tau-containing neurites and
higher activities of various tau kinases [21,39,40]. High inter-correlation
between levels of Aβ*56/Aβ1–42 and phospho-tau and a lack of CS effect
on tau phosphorylation in WT mice was also observed. These data, to-
gether with the increasing evidence of tau abnormalities as a secondary
event to amyloid pathology in the pathogenic continuum of AD
[40–42], invite to speculate that prevention of tau pathology by CS is like-
ly to be a consequence of reduced amyloid load.
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mice exposed to CS and naïve conditions after a lag of 9 months are
quite striking. Based on previous animal studies, which have suggested
that EE can impact a variety of processes involved with amyloid pro-
cessing [10,14,18], it is possible to speculate that CS may have reduced
the production of toxic Aβ species to further induce changes on the de-
velopment of other AD-related pathological events or cognitive impair-
ments. However, biochemical characterization at different time points
after the CS paradigm should be carried out in order to accurately assess
how big the delay caused by CS intervention could be. It would also be
of great interest to understand why CS effects are speciﬁc for Tg2576
mice. The observation that CS did not affect levels of murine Aβ1–42 in
WT mice implies that CS shows more beneﬁts under particular patho-
genic conditions, such as amyloid pathology, than under normal ageing.
However, themolecularmechanisms underlying the lowering effects of
CS on amyloid need to be elucidated.
EE has been used for several decades to study neuroanatomical
and behavioural changes associated with cognitive stimulation. The
application of EE to AD animal models has shown beneﬁcial effects
on cognitive and pathological symptoms. 5–6 months of EE in
young APP/PS1 mice improved performance in radial water maze
and in the classical and reversal version of MWM [8,10], and an EE
of 6 months in old APP23 mice also improved MWM performance
[9]. However, discrepancies have risen since not all the EE paradigms
have been able to reduce memory impairments. For example, shorter
durations of EE (2–4 months) failed to improve Y-maze or Barnes
maze performances in either TgCRND8 or APP/PS1mice [11,12]. Vary-
ing outcomes on amyloid pathology [9,12–14,17] have been also
reported. Most studies have shown increased or stable amyloid
plaque load after an EE ranging from 4 to 6 months [9,12,13], but
some studies with an EE ranging from 5 to 6 months have found de-
creased deposition of amyloid [14,17]. It is important to note that the
effect on amyloid pathology does not necessarily correlate with cog-
nitive function in most of these studies. EE protocols generally consist
of a set of different stimuli as running wheels, coloured tunnels, visual
stimulating toys, ladders and group housing [43], therefore providing
a complex interaction between social abilities, physical skills and
anti-stress environments. A novel approach to induce CS in WT and
Alzheimer's mice while avoiding enriched environments and social/
physical activities has been used and validated. The present ﬁndings
would thus provide empiric evidence on the relative beneﬁcial and
long-lasting contribution of an early-life CS paradigm on cognitive de-
cline associated to AD and, in particular, on some pathological pro-
cesses, such as synaptic, amyloid and tau pathologies.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbadis.2013.02.018.
Acknowledgements
This research was supported by the Spanish grants from FIS
(10/01748), CAN (“Tu eliges, Tu decides” projects) and FIMA (UTE
project). G. Gerenu is supported by a PhD scholarship from the Univer-
sity of Navarra (“Asociacion de Amigos”). The authorswant to thank the
staff members of Animal Facility andManagement Department at CIMA
for their support. The authors also thankMariluzMuro for her technical
assistance in the cryotome, and Ramon Murua and maintenance per-
sonnel from the University of Navarra for providing with material and
ideas to build the mazes.
References
[1] Y. Stern, Cognitive reserve and Alzheimer disease, Alzheimer Dis. Assoc. Disord.
20 (2006) S69–S74.
[2] T.D. Koepsell, B.F. Kurland, O. Harel, E.A. Johnson, X.H. Zhou, W.A. Kukull, Educa-
tion, cognitive function, and severity of neuropathology in Alzheimer disease,
Neurology 70 (2008) 1732–1739.[3] R. Andel, C. Vigen, W.J. Mack, L.J. Clark, M. Gatz, The effect of education and occu-
pational complexity on rate of cognitive decline in Alzheimer's patients, J. Int.
Neuropsychol. Soc. 12 (2006) 147–152.
[4] M.C. Carlson, M.J. Helms, D.C. Steffens, J.R. Burke, G.G. Potter, B.L. Plassman, Mid-
life activity predicts risk of dementia in older male twin pairs, Alzheimers
Dement 4 (2008) 324–331.
[5] J. Verghese, R.B. Lipton, M.J. Katz, C.B. Hall, C.A. Derby, G. Kuslansky, A.F. Ambrose,
M. Sliwinski, H. Buschke, Leisure activities and the risk of dementia in the elderly,
N. Engl. J. Med. 348 (2003) 2508–2516.
[6] S. Rovio, I. Kareholt, E.L. Helkala, M. Viitanen, B. Winblad, J. Tuomilehto, H.
Soininen, A. Nissinen, M. Kivipelto, Leisure-time physical activity at midlife and
the risk of dementia and Alzheimer's disease, Lancet Neurol. 4 (2005) 705–711.
[7] A.M. Owen, A. Hampshire, J.A. Grahn, R. Stenton, S. Dajani, A.S. Burns, R.J. Howard,
C.G. Ballard, Putting brain training to the test, Nature 465 (2010) 775–778.
[8] J.L. Jankowsky, T. Melnikova, D.J. Fadale, G.M. Xu, H.H. Slunt, V. Gonzales, L.H.
Younkin, S.G. Younkin, D.R. Borchelt, A.V. Savonenko, Environmental enrichment
mitigates cognitive deﬁcits in a mouse model of Alzheimer's disease, J. Neurosci.
25 (2005) 5217–5224.
[9] S.A. Wolf, G. Kronenberg, K. Lehmann, A. Blankenship, R. Overall, M. Staufenbiel,
G. Kempermann, Cognitive and physical activity differently modulate disease
progression in the amyloid precursor protein (APP)-23 model of Alzheimer's dis-
ease, Biol. Psychiatry 60 (2006) 1314–1323.
[10] D.A. Costa, J.R. Cracchiolo, A.D. Bachstetter, T.F. Hughes, K.R. Bales, S.M. Paul, R.F.
Mervis, G.W. Arendash, H. Potter, Enrichment improves cognition in AD mice by
amyloid-related and unrelated mechanisms, Neurobiol. Aging 28 (2007) 831–844.
[11] N. Gortz, L. Lewejohann, M. Tomm, O. Ambree, K. Keyvani, W. Paulus, N. Sachser,
Effects of environmental enrichment on exploration, anxiety, and memory in fe-
male TgCRND8 Alzheimer mice, Behav. Brain Res. 191 (2008) 43–48.
[12] M.C. Cotel, S. Jawhar, D.Z. Christensen, T.A. Bayer, O. Wirths, Environmental en-
richment fails to rescue working memory deﬁcits, neuron loss, and neurogenesis
in APP/PS1KI mice, Neurobiol. Aging 33 (2010) 96–107.
[13] J.L. Jankowsky, G. Xu, D. Fromholt, V. Gonzales, D.R. Borchelt, Environmental en-
richment exacerbates amyloid plaque formation in a transgenic mouse model of
Alzheimer disease, J. Neuropathol. Exp. Neurol. 62 (2003) 1220–1227.
[14] O. Lazarov, J. Robinson, Y.P. Tang, I.S. Hairston, Z. Korade-Mirnics, V.M. Lee, L.B.
Hersh, R.M. Sapolsky, K. Mirnics, S.S. Sisodia, Environmental enrichment reduces
Abeta levels and amyloid deposition in transgenic mice, Cell 120 (2005) 701–713.
[15] G.W. Arendash, M.F. Garcia, D.A. Costa, J.R. Cracchiolo, I.M. Wefes, H. Potter, Envi-
ronmental enrichment improves cognition in aged Alzheimer's transgenic mice
despite stable beta-amyloid deposition, Neuroreport 15 (2004) 1751–1754.
[16] J. Nithianantharajah, A.J. Hannan, Enriched environments, experience-dependent
plasticity and disorders of the nervous system, Nat. Rev. Neurosci. 7 (2006)
697–709.
[17] J.R. Cracchiolo, T. Mori, S.J. Nazian, J. Tan, H. Potter, G.W. Arendash, Enhanced cog-
nitive activity – over and above social or physical activity – is required to protect
Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and in-
crease synaptic immunoreactivity, Neurobiol. Learn. Mem. 88 (2007) 277–294.
[18] S. Mirochnic, S. Wolf, M. Staufenbiel, G. Kempermann, Age effects on the regula-
tion of adult hippocampal neurogenesis by physical activity and environmental
enrichment in the APP23 mouse model of Alzheimer disease, Hippocampus 19
(2009) 1008–1018.
[19] K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, G.
Cole, Correlative memory deﬁcits, Abeta elevation, and amyloid plaques in trans-
genic mice, Science 274 (1996) 99–102.
[20] B. Aisa, R. Tordera, B. Lasheras, J. Del Rio, M.J. Ramirez, Cognitive impairment
associated to HPA axis hyperactivity after maternal separation in rats,
Psychoneuroendocrinology 32 (2007) 256–266.
[21] M. Cuadrado-Tejedor, I. Hervias, A. Ricobaraza, E. Puerta, J.M. Perez-Roldan, C.
Garcia-Barroso, R. Franco, N. Aguirre, A. Garcia-Osta, Sildenaﬁl restores cognitive
function without affecting beta-amyloid burden in a mouse model of Alzheimer's
disease, Br. J. Pharmacol. 164 (2011) 2029–2041.
[22] D. Puzzo, L. Privitera, M. Fa, A. Staniszewski, G. Hashimoto, F. Aziz, M. Sakurai,
E.M. Ribe, C.M. Troy, M. Mercken, S.S. Jung, A. Palmeri, O. Arancio, Endogenous
amyloid-beta is necessary for hippocampal synaptic plasticity and memory,
Ann. Neurol. 69 (2011) 819–830.
[23] A. Mouri, Y. Noda, H. Hara, H. Mizoguchi, T. Tabira, T. Nabeshima, Oral vaccination
with a viral vector containing Abeta cDNA attenuates age-related Abeta accumu-
lation and memory deﬁcits without causing inﬂammation in a mouse Alzheimer
model, FASEB J. 21 (2007) 2135–2148.
[24] D. Morgan, D.M. Diamond, P.E. Gottschall, K.E. Ugen, C. Dickey, J. Hardy, K. Duff, P.
Jantzen, G. DiCarlo, D. Wilcock, K. Connor, J. Hatcher, C. Hope, M. Gordon, G.W.
Arendash, A beta peptide vaccination prevents memory loss in an animal model
of Alzheimer's disease, Nature 408 (2000) 982–985.
[25] M.A. Westerman, D. Cooper-Blacketer, A. Mariash, L. Kotilinek, T. Kawarabayashi,
L.H. Younkin, G.A. Carlson, S.G. Younkin, K.H. Ashe, The relationship between
Abeta and memory in the Tg2576 mouse model of Alzheimer's disease, J. Neurosci.
22 (2002) 1858–1867.
[26] G. Taglialatela, D. Hogan, W.R. Zhang, K.T. Dineley, Intermediate- and long-term
recognition memory deﬁcits in Tg2576 mice are reversed with acute calcineurin
inhibition, Behav. Brain Res. 200 (2009) 95–99.
[27] G. Neves, S.F. Cooke, T.V. Bliss, Synaptic plasticity, memory and the hippocampus:
a neural network approach to causality, Nat. Rev. Neurosci. 9 (2008) 65–75.
[28] M.E. Larson, S.E. Lesne, Soluble Abeta oligomer production and toxicity,
J. Neurochem. 120 (Suppl. 1) (2012) 125–139.
[29] Y. Tomidokoro, K. Ishiguro, Y. Harigaya, E. Matsubara, M. Ikeda, J.M. Park, K.
Yasutake, T. Kawarabayashi, K. Okamoto, M. Shoji, Abeta amyloidosis induces
847G. Gerenu et al. / Biochimica et Biophysica Acta 1832 (2013) 837–847the initial stage of tau accumulation in APP(Sw) mice, Neurosci. Lett. 299 (2001)
169–172.
[30] G.N. Patrick, L. Zukerberg, M. Nikolic, S. de la Monte, P. Dikkes, L.H. Tsai, Conver-
sion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration,
Nature 402 (1999) 615–622.
[31] L. Verret, A. Krezymon, H. Halley, S. Trouche, M. Zerwas, M. Lazouret, J.M. Lassalle,
C. Rampon, Transient enriched housing before amyloidosis onset sustains cogni-
tive improvement in Tg2576 mice, Neurobiol. Aging (in press).
[32] M. Verbitsky, A.L. Yonan, G. Malleret, E.R. Kandel, T.C. Gilliam, P. Pavlidis, Altered
hippocampal transcript proﬁle accompanies an age-related spatial memory deﬁ-
cit in mice, Learn. Mem. 11 (2004) 253–260.
[33] G. Chen, K.S. Chen, J. Knox, J. Inglis, A. Bernard, S.J. Martin, A. Justice, L.
McConlogue, D. Games, S.B. Freedman, R.G. Morris, A learning deﬁcit related to
age and beta-amyloid plaques in a mouse model of Alzheimer's disease, Nature
408 (2000) 975–979.
[34] D. Morgan, Learning and memory deﬁcits in APP transgenic mouse models of am-
yloid deposition, Neurochem. Res. 28 (2003) 1029–1034.
[35] S. Lesne, M.T. Koh, L. Kotilinek, R. Kayed, C.G. Glabe, A. Yang, M. Gallagher, K.H.
Ashe, A speciﬁc amyloid-beta protein assembly in the brain impairs memory,
Nature 440 (2006) 352–357.
[36] I.H. Cheng, K. Scearce-Levie, J. Legleiter, J.J. Palop, H. Gerstein, N. Bien-Ly, J.
Puolivali, S. Lesne, K.H. Ashe, P.J. Muchowski, L. Mucke, Accelerating amyloid-
beta ﬁbrillization reduces oligomer levels and functional deﬁcits in Alzheimer
disease mouse models, J. Biol. Chem. 282 (2007) 23818–23828.[37] L.M. Billings, K.N. Green, J.L. McGaugh, F.M. LaFerla, Learning decreases A beta*56
and tau pathology and ameliorates behavioral decline in 3xTg-AD mice,
J. Neurosci. 27 (2007) 751–761.
[38] R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, C.G.
Glabe, Common structure of soluble amyloid oligomers implies common mecha-
nism of pathogenesis, Science 300 (2003) 486–489.
[39] I. Ferrer, T. Gomez-Isla, B. Puig, M. Freixes, E. Ribe, E. Dalfo, J. Avila, Current ad-
vances on different kinases involved in tau phosphorylation, and implications in
Alzheimer's disease and tauopathies, Curr. Alzheimer Res. 2 (2005) 3–18.
[40] C. Otth, I.I. Concha, T. Arendt, J. Stieler, R. Schliebs, C. Gonzalez-Billault, R.B.
Maccioni, AbetaPP induces cdk5-dependent tau hyperphosphorylation in trans-
genic mice Tg2576, J. Alzheimers Dis. 4 (2002) 417–430.
[41] D.E. Hurtado, L. Molina-Porcel, M. Iba, A.K. Aboagye, S.M. Paul, J.Q. Trojanowski,
V.M. Lee, A{beta} accelerates the spatiotemporal progression of tau pathology
and augments tau amyloidosis in an Alzheimer mouse model, Am. J. Pathol. 177
(2010) 1977–1988.
[42] M. Jin, N. Shepardson, T. Yang, G. Chen, D. Walsh, D.J. Selkoe, Soluble amyloid
beta-protein dimers isolated from Alzheimer cortex directly induce Tau
hyperphosphorylation and neuritic degeneration, Proc. Natl. Acad. Sci. U. S. A.
108 (2011) 5819–5824.
[43] Y.S. Hu, P. Xu, G. Pigino, S.T. Brady, J. Larson, O. Lazarov, Complex environment ex-
perience rescues impaired neurogenesis, enhances synaptic plasticity, and atten-
uates neuropathology in familial Alzheimer's disease-linked APPswe/PS1DeltaE9
mice, FASEB J. 24 (2010) 1667–1681.
